HealthBeacon, a Dublin-based medical technology company that plans to float on the stock market with a valuation of €100 million, had revenues of €1.2 million in 2020 and recorded a loss from continuing operations of €3.4 million. The company, however, is predicting that it is on the brink of growing explosively from 4,585 units deployed in 2020 to 100,000 by the end of 2023. HealthBeacon has developed a solution that helps patients better adhere to injectable medications schedules across seven therapeutic areas such as respiratory, rheumatology, and neurology. It is selling 25 per cent of its shares to raise €25…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .